Feedback / Questions
Allovectin-7 (velimogene aliplasmid) - AnGes MG, Brickell
Citi Global Healthcare Conference
(Vical)
-
Mar 3, 2011 -
Allovectin-7 / Vical; P3 ongoing with commercial opportunity >$500 million & database lock expected in H2 ‘11 for MM
Melanoma
http://www.larvolonline.com/tlg/ccdb/VicalCitiGlobalHealthcareConfMar3.pdf
Mar 3, 2011
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious